)
XWELL (XWEL) investor relations material
XWELL Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
July 6, 2026 agreement proposes a $13 million base-price sale, subject to adjustments, of the airport spa and testing businesses to Express Wellness Group; closing is expected in Q4 2026, subject to approval and other conditions.
Twelve non-airport wellness locations would be retained; sale proceeds would fund their continued operation and potential strategic acquisitions or business combinations, with no distribution to stockholders planned.
The Board cited liquidity pressures, sustained spa losses and XpresTest's dependence on a single CDC customer in favor of the sale and redeployment of capital.
Voting matters and shareholder proposals
The October 28, 2026 virtual meeting will consider the sale, an advisory sale-compensation vote, a 2020 Plan share-reserve increase and authority to adjourn for more proxies; the Board recommends FOR all four.
Sale approval requires a majority of outstanding common shares; each other proposal requires a majority of votes cast. Abstentions and non-votes count against the sale, while abstentions have no effect on the other proposals.
As of October 7, 9,970,883 common shares were outstanding; quorum requires one-third of eligible votes. Support parties committed to vote FOR the sale and held about 28.1% of outstanding shares.
Failure to approve the sale prevents closing even if the other proposals pass; the sale-compensation and plan proposals are not closing conditions.
Board of directors and corporate governance
The Board unanimously found the sale advisable and in stockholders' best interests, directed a stockholder vote and recommended approval of the Purchase Agreement.
Roth Capital Partners opined on July 6, 2026 that the consideration was fair to the seller from a financial point of view; its opinion was not a recommendation on how stockholders should vote.
The Board considered directors' and executives' differing sale interests and determined recusal was unnecessary, citing the majority's lack of a different financial interest and the pre-existing nature of certain awards.
- Q2 2026 saw revenue down 7% YoY, a narrowed loss, and a $13M airport business sale announced.XWEL
Q2 2026 - Shareholders are to vote on a $13M divestiture, with proceeds retained for strategic use.XWEL
Proxy filing - $6.6M revenue, $11.2M net loss, and $28.3M raised to improve liquidity and simplify capital structure.XWEL
Q1 2026 - Registration of 138.7M shares for resale may cause substantial dilution to existing holders.XWEL
Registration filing - 2025 revenue hit $29.2M, with cost reductions and new capital fueling expansion and innovation.XWEL
Q4 2025 - Board recommends approval of all annual meeting proposals, including reverse split and share issuance.XWEL
Proxy Filing - Annual meeting to vote on directors, auditor, executive pay, and tax asset protection plan.XWEL
Proxy Filing - Board recommends voting for all proposals, including director elections and tax asset protection.XWEL
Proxy Filing - Stockholders to vote on equity issuance, board structure, plan amendments, and auditor ratification.XWEL
Proxy Filing
Next XWELL earnings date
Next XWELL earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage